We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$618M
AUM Growth
+$34.4M
Cap. Flow
-$12M
Cap. Flow %
-1.95%
Top 10 Hldgs %
23.3%
Holding
492
New
15
Increased
–
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$318K
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$259K
3
MAN icon
ManpowerGroup
MAN
+$241K
4
UHS icon
Universal Health Services
UHS
+$236K
5
IR icon
Ingersoll Rand
IR
+$225K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.1M
2
CTXS
Citrix Systems Inc
CTXS
+$2.08M
3
KLAC icon
KLA
KLAC
+$1.36M
4
ORCL icon
Oracle
ORCL
+$912K
5
ITW icon
Illinois Tool Works
ITW
+$745K

Sector Composition

Rank Sector Weight
1 Technology 23.28%
2 Healthcare 15.2%
3 Financials 13.94%
4 Industrials 12.19%
5 Consumer Discretionary 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$35.4M 5.72%
272,200
-5,200
-2% -$743K
MSFT icon
2
Microsoft
MSFT
$3.45T
$32.2M 5.21%
134,300
– –
AMZN icon
3
Amazon
AMZN
$2.92T
$12.2M 1.98%
145,800
– –
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.36T
$11.3M 1.83%
127,700
– –
JPM icon
5
JPMorgan Chase
JPM
$935B
$10M 1.62%
74,800
-3,700
-5% -$469K
JNJ icon
6
Johnson & Johnson
JNJ
$618B
$9.72M 1.57%
55,000
– –
LLY icon
7
Eli Lilly
LLY
$1.02T
$8.95M 1.45%
24,460
-1,800
-7% -$638K
MRK icon
8
Merck
MRK
$322B
$8.9M 1.44%
80,252
– –
XOM icon
9
ExxonMobil
XOM
$644B
$8.29M 1.34%
75,200
– –
PG icon
10
Procter & Gamble
PG
$336B
$6.93M 1.12%
45,700
– –
WMT icon
11
Walmart Inc
WMT
$885B
$5.67M 0.92%
120,000
– –
CVX icon
12
Chevron
CVX
$392B
$5.64M 0.91%
31,400
– –
AMT icon
13
American Tower
AMT
$80.8B
$5.34M 0.86%
25,200
– –
AXP icon
14
American Express
AXP
$227B
$5.33M 0.86%
36,100
– –
GOOGL icon
15
Alphabet (Google) Class A
GOOGL
$4.36T
$5.08M 0.82%
57,600
– –
GS icon
16
Goldman Sachs
GS
$300B
$4.65M 0.75%
13,550
– –
CSCO icon
17
Cisco
CSCO
$457B
$4.62M 0.75%
97,000
– –
UNP icon
18
Union Pacific
UNP
$174B
$4.56M 0.74%
22,000
– –
ORCL icon
19
Oracle
ORCL
$374B
$4.5M 0.73%
55,000
-12,000
-18% -$912K
MRSH
20
Marsh
MRSH
$90.5B
$4.47M 0.72%
27,000
– –
CMCSA icon
21
Comcast
CMCSA
$85B
$4.44M 0.72%
127,000
– –
MCD icon
22
McDonald's
MCD
$192B
$4.35M 0.7%
16,493
– –
LRCX icon
23
Lam Research
LRCX
$367B
$4.3M 0.7%
102,250
– –
META icon
24
Meta Platforms (Facebook)
META
$1.42T
$4.25M 0.69%
35,300
– –
TRV icon
25
Travelers Companies
TRV
$78.1B
$4.21M 0.68%
22,443
– –
1
2 3 4 5

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q4 2022 Portfolio in Review

As of Q4 2022, NJ State Employees Deferred Compensation Plan held 492 positions worth $618M, up 5.9% from $584M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.9%. NJ State Employees Deferred Compensation Plan opened 15 new positions and exited 9, leaving the 492-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • NJ State Employees Deferred Compensation Plan's largest Q4 2022 buy was Apellis Pharmaceuticals: 6,000 shares worth $310K.
  • NJ State Employees Deferred Compensation Plan's biggest Q4 2022 reduction was KLA, cutting an estimated $1.36M.
  • NJ State Employees Deferred Compensation Plan fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $3.1M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 23% of its $618M portfolio in Q4 2022.
  • NJ State Employees Deferred Compensation Plan opened 15 new positions and closed 9 in Q4 2022.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 5.9% quarter-over-quarter to $618M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2022, filed 26 Jan 2023.